Digital therapeutics (DTx) are emerging to prevent, manage, and even treat medical conditions such as diabetes, asthma, depression, and opioid addiction. But where do they fit in terms of managed care access and reimbursement? As more and more clinically validated digital health tools and therapeutics come to market, it is important for payers to understand how traditional formulary management tools can be used to manage these new treatments. DTx require standards and evidence that meet the needs of physicians, payers, and patients. And while the assessment, selection, and management of DTx requires intensive clinical review and critical, objective validation, the digital therapeutic formulary is a valuable tool. The Covid-19 pandemic has exposed the challenges in delivering accessible high-quality care outside of traditional office-based visits, and more patients and clinicians are turning to digital solutions. When it comes to DTx, the safety and health of patients depends on how well traditional formulary management tools perform in assessing the technical, clinical, usability, and cost of digital therapeutics.
In this session, faculty will review the trends in the development of DTx over the past decade, the current landscape, use of DTx formularies, and how some payers are reimbursing for DTx applications.
- Describe how digital therapeutic formularies are developed and what evidence is available.
- Describe how various payers are reimbursing for digital therapeutics.
- Discuss the impact of the COVID-19 pandemic on use of digital therapeutics.
- Discuss the impact of Digital Health tools to Care Coordination.
Schedule of Educational Activity:
This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-21-023-H04-P • Activity Type: Knowledge-Based
Contact Hours: 1
Release Date: May 5, 2021 • Expiration Date: December 31, 2022
Activity Fee: $15 for members and $30 for non-members.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2021 Virtual.CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-21-023-H04-P||1 Contact Hour||April 16, 2021 - December 31, 2022|